Faculty profile

Ravi Retnakaran

ResearcherEndocrinology and MetabolismUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Ravi Retnakaran

Researcher

Endocrinology and Metabolism

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
76 publications in the last five years, latest in 2026.
Senior (last) author on 12 recent papers, a sign of leading a research group.
Principal investigator on 22 research grants (22 CIHR), most recently in 2026.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

244

Publications

1,045

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Women'S Health Gestational Diabetes Preconception Beta-Cell Function Type 2 Diabetes Adiponectin Insulin Resistance Lifestyle Intervention

Latest papers

Exenatide induces an enhanced endogenous glucagon-like peptide-1 secretory response in patients receiving basal insulin.
The Journal of clinical endocrinology and metabolism · 2026 · senior author
Antecedent of Pregnancy-Related Cardiometabolic Complication and Risk of Cardiovascular Disease Among Women With Type 2 Diabetes.
Diabetes, obesity & metabolism · 2026
Evaluation of new staging schema for the early diagnosis of dysglycaemia.
The lancet. Diabetes & endocrinology · 2026 · first author

All 244 publications

Latest funding

Unpacking the Impact of Ultra-Processed Food on Youth Cardiovascular Health: A Multi-Omic, Translational Approach
CIHR · 2026 · Co-investigator
$10,000
Intervening across the first 2000 Days of Life to Transform a Lifetime
CIHR · 2026 · Nominated PI
$930,874
Metformin for treatment-resistant bipolar depression (TRBD) with co-morbid insulin resistance (IR): A double-blind randomized control trial
CIHR · 2025 · Co-investigator
$1,510,875

All 42 grants and awards

From the 150 most recent of 244 publications.

Exenatide induces an enhanced endogenous glucagon-like peptide-1 secretory response in patients receiving basal insulin.

Parikh M, Pu J, Shen J, Kramer CK, Zinman B, Beaudry JL, Retnakaran R

The Journal of clinical endocrinology and metabolism2026Senior author

DOI: 10.1210/clinem/dgag033 PMID: 41604435

Antecedent of Pregnancy-Related Cardiometabolic Complication and Risk of Cardiovascular Disease Among Women With Type 2 Diabetes.

Echouffo-Tcheugui JB, McCormack D, Ke C, Retnakaran R, Shah BR

Diabetes, obesity & metabolism2026

DOI: 10.1111/dom.71119 PMID: 42481915

Evaluation of new staging schema for the early diagnosis of dysglycaemia.

Retnakaran R, Shen J, Bergman M, Hanley AJ, Zinman B

The lancet. Diabetes & endocrinology2026First author

DOI: 10.1016/s2213-8587(26)00007-0 PMID: 41839193

The impact of COVID-19 illness on metabolic phenotypes underlying type 2 diabetes mellitus: a systematic review.

Li M, Sharma K, Chon JE, Yehia NA, Retnakaran R, Harris SB, Hanley AJ

Diabetes research and clinical practice2026

DOI: 10.1016/j.diabres.2026.113163 PMID: 41763558

The Effect of Semaglutide on Antipsychotic-Induced Weight Gain and Other Metabolic Parameters, among a Cohort of Inpatients.

De R, Amin Alfatwa Y, Kanagasundaram P, Saragosa JE, Chan J, Remington G, Retnakaran R, Sanches M, Sockalingam S, Agarwal SM, Hahn MK

Schizophrenia bulletin2026

DOI: 10.1093/schbul/sbaf236 PMID: 42297449

Glucose-lowering in type 2 diabetes may be mediated by improved proinsulin processing without better β-cell compensation.

Retnakaran R, Shen J, Parikh M, Hanley AJ, Zinman B, Beaudry JL

American journal of physiology. Endocrinology and metabolism2026First author

DOI: 10.1152/ajpendo.00163.2026 PMID: 42721371

Impact of an Additional Pregnancy on the Natural History of Insulin Sensitivity, β-Cell Function, and Glycemia in Parous Women.

Retnakaran R, Shen J, Hanley AJ, Zinman B

Diabetes care2026First author

DOI: 10.2337/dc25-2354 PMID: 41706446

Preconception mental health (Healthy Life Trajectories Initiative): Identifying factors associated with probable anxiety and depression among young women living in urban-poor South Africa.

Norris SA, Hart C, Nyati LH, Taljaard W, Hung RJ, Retnakaran R, Lye S, Draper CE, Craig A

PLOS mental health2026

DOI: 10.1371/journal.pmen.0000578 PMID: 41875168

Impact of Liraglutide on Insulin Clearance in Patients with Type 2 Diabetes Mellitus: Evidence from a Randomized Controlled Trial.

Boelling M, Pu J, Shen J, Retnakaran R

Diabetes & metabolism journal2026Senior author

DOI: 10.4093/dmj.2025.1081 PMID: 41813267

Dual Energy X-Ray Absorptiometry Reveals Differential Glycemic Implications of Adiposity in Underweight, Normal Weight, and Overweight South African Women With Newly-Diagnosed Diabetes.

Retnakaran R, Shen J, Hung RJ, Micklesfield LK, Lye SJ, Norris SA

Diabetes, obesity & metabolism2026First author

DOI: 10.1111/dom.71333 PMID: 42712038

Something wrong or missing on this profile? Suggest a correction

Ravi Retnakaran

Research

Latest papers

Latest funding

Exenatide induces an enhanced endogenous glucagon-like peptide-1 secretory response in patients receiving basal insulin.

Antecedent of Pregnancy-Related Cardiometabolic Complication and Risk of Cardiovascular Disease Among Women With Type 2 Diabetes.

Evaluation of new staging schema for the early diagnosis of dysglycaemia.

The impact of COVID-19 illness on metabolic phenotypes underlying type 2 diabetes mellitus: a systematic review.

The Effect of Semaglutide on Antipsychotic-Induced Weight Gain and Other Metabolic Parameters, among a Cohort of Inpatients.

Glucose-lowering in type 2 diabetes may be mediated by improved proinsulin processing without better &#x3b2;-cell compensation.

Impact of an Additional Pregnancy on the Natural History of Insulin Sensitivity, &#x3b2;-Cell Function, and Glycemia in Parous Women.

Preconception mental health (Healthy Life Trajectories Initiative): Identifying factors associated with probable anxiety and depression among young women living in urban-poor South Africa.

Impact of Liraglutide on Insulin Clearance in Patients with Type 2 Diabetes Mellitus: Evidence from a Randomized Controlled Trial.

Dual Energy X-Ray Absorptiometry Reveals Differential Glycemic Implications of Adiposity in Underweight, Normal Weight, and Overweight South African Women With Newly-Diagnosed Diabetes.

Frequent collaborators

Bernard Zinman

Mathew Sermer

Hertzel Gerstein

Howard Berger

Nir Melamed

Adria Giacca

Minna Woo

Natalia McInnes

Anthony Hanley

Gary Sweeney

Daniel Krewski

Sarah McDonald

Beth Murray Davis

Catherine Birken

Vladimir Vuksan

Jon Barrett

Jill Hamilton

Jacquetta Trasler

Bruce Perkins

Lillian Sung

John Floras

Azadeh Kushki

Lisa Richardson

Vasanti Malik

Gregory Steinberg

Sean Wharton

Glucose-lowering in type 2 diabetes may be mediated by improved proinsulin processing without better β-cell compensation.

Impact of an Additional Pregnancy on the Natural History of Insulin Sensitivity, β-Cell Function, and Glycemia in Parous Women.